On‐target sorafenib toxicity predicts improved survival in hepatocellular carcinoma: a multi‐centre, prospective study

Jessica Howell; David J. Pinato; Ramya Ramaswami; Dominik Bettinger; Tadaaki Arizumi; Cecilia Ferrari; Clarence Yen; Antonello Gibbin; Michela Emma Burlone; Giulia Guaschino; L. Sellers; James R. Black; Mario Pirisi; Masatoshi Kudo; Robert Thimme; J.‐W. Park; Rohini Sharma

doi:10.1111/apt.13977

Related publications

Article2018

Predictor factor of survival in advanced hepatocellular carcinoma treated with sorafenib ∼a multicenter study∼

Chikara Ogawa, Masahiro Morita, Akina Omura, Mitsushige Shibatoge, Akemi Tsutsui, Tomonori Senoh, Takuya Nagano, Kouichi Takaguchi, Joji Tani, Asahiro Morishita, Hirohito Yoneyama, Tsutomu Masaki, Akio Moriya, Masaharu Ando, Akihiro Deguchi, Masatoshi Kudo

Article2007

Sorafenib Improves Survival in Hepatocellular Carcinoma: Results of a Phase 3 Randomized, Placebo-Controlled Trial

Caroline Helwick, Josep M. Llovet

MD Conference Express

Article2012

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma: Subanalyses of a phase III trial

Jordi Bruix, Jean‐Luc Raoul, Morris Sherman, Vincenzo Mazzaferro, Luigi Bolondi, Antonio Craxı̀, Peter R. Galle, Armando Santoro, Michel Beaugrand, Angelo Sangiovanni, Camillo Porta, Guido Gerken, Jorge A. Marrero, Andrea Nadel, Michael Shan, M. Moscovici, D. Voliotis, Josep M. Llovet

Journal of Hepatology

Article2009

Impact of lymph node metastases on outcome following treatment with sorafenib in patients with hepatocellular carcinoma (HCC): Subset analysis from the phase III SHARP trial

Jean‐Luc Raoul, Antonio Craxı̀, Camillo Porta, Giuseppe Lentini, Andrea Nadel, D. Voliotis, Jordi Bruix, Josep M. Llovet

Journal of Clinical Oncology

Article2008

Efficacy and safety of sorafenib in patients with advanced hepatocellular carcinoma and vascular invasion or extrahepatic spread: A subanalysis from the SHARP trial

Morris Sherman, Vincenzo Mazzaferro, D. Amadori, Julia Seitz, M. Moscovici, Ming Shan, Andrea Nadel, D. Voliotis, Josep M. Llovet, Jordi Bruix